Omnicell Corp (OMCL): Rasio rega marang pendapatan

Simbol lan logo merek Omnicell Corp (OMCL)

Top management updates and the adaptation of the governance structure are currently driving the price action. The P/S trajectory clearly demonstrates these changes, where the value of 1.30 characterizes this valuation level. Growth is supported by SaaS solutions and warehouse robotics amid healthcare staffing shortages. The Omnicell, Inc. (OMCL) strategy is based on minimizing medical errors through the global implementation of cloud-based medication management systems.

omnicell.com - Kapitalisasi marang pendapatan OMCL (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan Omnicell Corp (OMCL)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:OMCL (omnicell.com)
Barang utama omnicell.com

Steady growth in the subscription IT segment of Omnicell, Inc. (OMCL) reduces reliance on cyclical hardware sales, making the company's revenue more predictable. This price-to-sales valuation compares market capitalization with annual turnover, allowing investors to identify if the asset is overbought by analyzing the deviation of the current multiple from historical averages to avoid entering a position at a local price peak.

Karo sapa Omnicell, Inc. saingan

VEEV - Rega marang dodolan|Rasio rega marang pendapatan Doximity DOCS|HealthEquity Inc - Rasio rega marang pendapatan|WAY - Rasio rega marang pendapatan|CRVL: Rasio rega marang pendapatan|PRVA (Privia Health Group) - Kapitalisasi marang pendapatan|huronconsultinggroup.com - Rasio kapitalisasi pasar marang pendapatan|CERT (Certara) - Multiplikator P/S|GoodRx Inc (GDRX) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Schrödinger Inc. (SDGR)|Phreesia Health - Rasio kapitalisasi marang pendapatan|Multiplikator P/S OMDA (Omada Health Inc)|EVH - Kapitalisasi marang pendapatan|HSTM: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Definitive Healthcare Corp DH|Consensus (CCSI) - Rasio rega marang pendapatan|Rega marang dodolan Agilon Health Corp (AGL)|Rasio rega marang pendapatan Absci|Kapitalisasi marang pendapatan soyoung.com (SY)|Multiplikator P/S NRC|Kapitalisasi marang pendapatan Spok Holdings Inc SPOK|Rasio rega marang pendapatan OptimizeRx Corp. OPRX|TruBridge Corp - Rasio rega marang pendapatan|Simulations Plus, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan SOPHiA GENETICS SA SOPH|HCAT (Health Catalyst) - Kapitalisasi marang pendapatan|CCLD: Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan RSSS|DLHC: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan OneMedNet Corporation (ONMD)|Kapitalisasi marang pendapatan scienture.com SCNX|Multiplikator P/S HCTI (Healthcare Triangle, Inc.)|iSpecimen Inc (ISPC) - Rega marang dodolan|Bullfrog AI Holdings Inc - Multiplikator P/S|WORX (SCWorx Inc) - Rasio kapitalisasi marang pendapatan|MSP Recovery Inc (MSPR) - Rasio rega marang pendapatan|Rega marang dodolan iCoreConnect (ICCT)|Rasio rega marang pendapatan TRxADE HEALTH|Kapitalisasi marang pendapatan Orgenesis Inc (ORGS)|Rasio rega marang pendapatan R1 RCM Inc. (RCM)|Sharecare Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S STRM (Streamline Health Solutions)|Koefisien rega marang pendapatan syrahealth.com (SYRA)|ApolloMed - Multiplikator P/S|Model N Inc (MODN) - Kapitalisasi marang pendapatan|NXGN: Multiplikator P/S